Onderzoeker
Katrien Vandecasteele
- Trefwoorden:pelvien gynaecologische tumoren
- Disciplines:Morfologische wetenschappen, Bestralingstherapie, Kankertherapie
Affiliaties
- Vakgroep Structuur en Herstel van de Mens (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Radiotherapie en Experimenteel Kankeronderzoek (Departement)
Lid
Vanaf29 aug 2008 → 30 sep 2018
Publicaties
1 - 10 van 11
- Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort(2023)
Auteurs: Axel Van Damme, Julie Rombaut, Amin Makar, Emiel De Jaeghere, Eline Naert, Hannelore Denys, Philippe Tummers, Katrien Vandecasteele
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study(2023)
Auteurs: Emiel De Jaeghere, Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.
Pagina's: 475 - 491 - 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial(2022)Volume: 32
Auteurs: Emiel De Jaeghere, Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.
Pagina's: A187 - A188 - Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer(2021)
Auteurs: B.G. Wortman, E. Astreinidou, M.S. Laman, E.M. van der Steen-Banasik, L.C.H.W. Lutgens, H. Westerveld, F. Koppe, A. Slot, H.A. van den Berg, M.E. Nowee, et al.
Pagina's: 160 - 166 - Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients(2020)
Auteurs: Hans Van Hulle, Vincent Vakaet, Giselle Post, Annick Van Greveling, Christel Monten, An Hendrix, Koen Van de Vijver, Jo Van Dorpe, Pieter De Visschere, Geert Braems, et al.
- PORTEC-4a : international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer(2020)
Auteurs: Anne Sophie V. M. van den Heerik, Nanda Horeweg, Remi A. Nout, Ludy C. H. W. Lutgens, Elzbieta M. van der Steen-banasik, G. Henrike Westerveld, Hetty A. van den Berg, Annerie Slot, Friederike L. A. Koppe, Stefan Kommoss, et al.
Pagina's: 2002 - 2007 - PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer(2019)
Auteurs: Sandra Tuyaerts, An MT Van Nuffel, Eline Naert, Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, et al.
- EXclusion of non-Involved uterus from the Target Volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques(2018)
Auteurs: Katrien Vandecasteele, Philippe Tummers, Mieke Van Bockstal, Pieter De Visschere, Werner De Gersem, Hannelore Denys, Eline Naert, Amin Makar, Wilfried De Neve
- Dual registration for optimal cone beam computed tomography registration for locally advanced cervix carcinoma(2016)Volume: 96
Auteurs: Evelien Bogaert, LUDWIG VAN DEN BERGHE, ANNE-LEEN MICHIELS, Carlos De Wagter, Yolande Lievens, Katrien Vandecasteele
Pagina's: E320 - E320 - EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression(2014)
Auteurs: KATRIJN VAN ASSCHE, Liesbeth Ferdinande, Yolande Lievens, Katrien Vandecasteele, Veerle Surmont